David Wofsy1. Show Affiliations » 1. University of California, San Francisco.
Abstract
Entities: Chemical Disease
Mesh： See more » Antibodies, Monoclonal, Humanized/therapeutic useClinical Trials, Phase II as Topic/standardsClinical Trials, Phase III as Topic/standardsDrug ApprovalHumansLupus Erythematosus, Systemic/drug therapyPublication BiasRandomized Controlled Trials as Topic/standardsUnited StatesUnited States Food and Drug Administration
Substances： See more » Antibodies, Monoclonal, Humanizedanifrolumab
Year: 2020 PMID： 32182394 DOI： 10.1002/art.41261
Source DB: PubMed Journal: Arthritis Rheumatol ISSN： 2326-5191 Impact factor: 10.995